Neovision Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Neovision Capital is an investment firm dedicated to both early and growth-stage investment in Chinese healthcare and TMT sectors.
Investor Profile
Neovision Capital has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Cloud Data Services, Information Technology, Medical.
Stage Focus
- Series D (40%)
- Post Ipo Equity (20%)
- Series B (20%)
- Series A (20%)
Country Focus
- China (100%)
Industry Focus
- Cloud Data Services
- Information Technology
- Medical
- Electrical Distribution
- Energy
- Industrial Engineering
- Manufacturing
- Leasing
- Peer To Peer
- Recycling
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
